Medium Chain Triglycerides (MCT Oil)
**Medium Chain Triglycerides (MCTs)** are specialized lipid fractions (primarily caprylic [C8] and capric [C10] saturated fatty acids) derived from coconut oil. They are utilized in veterinary medicine primarily as an easily digestible caloric source for patients with compromised gastrointestinal fat absorption. **Key Clinical Uses:** * **Fat Malabsorption Syndromes:** Used to provide calories to dogs with restricted long-chain fat intake due to conditions like **protein-losing enteropathy (PLE)**, **lymphangiectasia**, **exocrine pancreatic insufficiency (EPI)**, or severe **inflammatory bowel disease (IBD)**. * **Drug Vehicle:** Highly accepted by cats as a base-vehicle for compounding or administering oral medications. *Clinical Pearl:* While MCT oil provides readily available calories, it **does not contain essential fatty acids** (like linoleic acid). Patients on long-term ultra-low-fat diets supplemented only with MCT oil may require separate essential fatty acid supplementation. Today, many clinicians prefer using highly digestible, ultra-low-fat commercial prescription diets over adding MCT oil to homemade diets due to palatability issues.
กลไกการออกฤทธิ์: MCTs bypass the traditional, complex lipid digestion and absorption pathways required by long-chain triglycerides (LCTs): **Triglycerides** → hydrolyzed by **gastric and pancreatic lipases** (requires significantly less bile acids than LCTs) → **Medium-chain fatty acids (MCFAs)** → absorbed directly into enterocytes → enter the **portal vein** directly (bypassing **chylomicron** formation and **lymphatic transport**) → rapid oxidation in the liver for immediate energy. Because they do not rely on the lymphatic system, they are ideal for patients with lymphatic obstruction or dilation (e.g., lymphangiectasia).
ขนาดยาตามชนิดสัตว์
- Base-vehicle to administer drugs · 0.1 mL/kg · PO · as needed · Owner-perceived acceptability by cats of MCT oil was significantly higher than gelatin capsules.
- To offset caloric reduction when long-chain triglycerides are restricted · ½-4 teaspoons divided per day with food · PO · divided daily
- To offset caloric reduction when long-chain triglycerides are restricted · 0.5-2 mL/kg per day added to food · PO · daily
- To offset caloric reduction when long-chain triglycerides are restricted · 1-2 mL/kg per day · PO · daily
ขนาดยาเป็นข้อมูลอ้างอิงทางคลินิกสำหรับสัตวแพทย์ผู้มีใบอนุญาต โปรดตรวจสอบกับฉลากล่าสุดและผู้ป่วยแต่ละรายเสมอ
วิธีการให้ยา
ข้อห้ามใช้
- Significant hepatic disease (e.g., portosystemic shunts, cirrhosis, hepatic failure)
อาการไม่พึงประสงค์
- Unpalatability (especially in dogs)
- Bloating
- Flatulence
- Diarrhea
- Food aversion (rare in cats)
อันตรกิริยาระหว่างยา
- Griseofulvin · MCT oil may decrease absorption, as griseofulvin requires long-chain dietary fats for optimal oral absorption.
- Fat-soluble vitamins (A, D, E, K) · Absorption may be impaired if LCTs are completely replaced by MCTs; supplementation may be required.
การติดตาม
- Gastrointestinal tolerance (vomiting, bloating, flatulence, stool consistency)
- Efficacy (maintenance of body weight and body condition score)
- Signs of hepatic encephalopathy in patients with underlying liver disease
การได้รับยาเกินขนาด
Overdosage primarily exacerbates gastrointestinal adverse effects, leading to **bloating, flatulence, and severe diarrhea**. **Treatment:** * Discontinue or reduce the dose of MCT oil. * Treat severe diarrhea supportively (e.g., fluid therapy to correct dehydration and electrolyte imbalances) if necessary.
ข้อมูลอ้างอิงยาของ VetSheet มีไว้สำหรับสัตวแพทย์ผู้มีใบอนุญาตเพื่อช่วยในการตัดสินใจทางคลินิก ไม่ใช่สิ่งทดแทนการวินิจฉัยของผู้เชี่ยวชาญหรือฉลากล่าสุดของผู้ผลิต